LXR RECEPTOR MODULATORS

摘要

The invention relates to compounds which are derived from benzenesulfonamide of general formula (I) as described in the claims, and to the pharmaceutically acceptable addition salts thereof. The invention also relates to a method for the preparation thereof, pharmaceutical compositions containing them, and to the use thereof as a pharmacologically active substance in the treatment of neurodegeneracy, cardiovascular and inflammatory disease, hypecholesterolemia and diabetes.